MedTrace Logo

Safety and Efficacy of DUO Extended Set: Combined Glucose Sensor and Infusion Set.

NCT04810780 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-05-17

No results posted yet for this study

Summary

The study will follow subjects for 28 days while using an DUO extended infusion set combined with glucose sensor. the objective is to evaluate saftey and efficacy of the set in adult patient with type 1 diabetes.

Conditions

Interventions

DEVICE

DUO Extended Set

to evaluate saftey and efficacy of DUO extended set combined with glucose sensor

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • amir Tirosh, MD PhD · Sheba Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-06-01
Completion
2021-12-01

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04810780 on ClinicalTrials.gov